Erlotinib Response in a Non-Small Cell Lung Cancer Patient with EGFR Exon 20 Mutation

dc.contributor.authorKorkmaz, Levent
dc.contributor.authorArtac, Mehmet
dc.contributor.authorKaraagac, Mustafa
dc.contributor.authorEr, Zehra
dc.contributor.authorBoruban, Melih C.
dc.contributor.authorPoyraz, Necdet
dc.contributor.authorKaya, Bugra
dc.date.accessioned2024-02-23T14:48:52Z
dc.date.available2024-02-23T14:48:52Z
dc.date.issued2016
dc.departmentNEÜen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.identifier.endpage66en_US
dc.identifier.issn1306-133X
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-84962449564en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage64en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12452/17849
dc.identifier.volume26en_US
dc.identifier.wosWOS:000373662500009en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherAkad Doktorlar Yayinevien_US
dc.relation.ispartofUhod-Uluslararasi Hematoloji-Onkoloji Dergisien_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleErlotinib Response in a Non-Small Cell Lung Cancer Patient with EGFR Exon 20 Mutationen_US
dc.typeLetteren_US

Dosyalar